130 related articles for article (PubMed ID: 29398800)
1. Role of BAALC Gene in Prognosis of Acute Lymphoblastic Leukemia in Egyptian Children.
Hagag AA; Elshehaby WA; Hablas NM; Abdelmageed MM; Abd El-Lateef AE
Indian J Hematol Blood Transfus; 2018 Jan; 34(1):54-61. PubMed ID: 29398800
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of brain and acute leukemia cytoplasmic gene expression in egyptian children with acute myeloid leukemia.
Hagag AA; El-Lateef AE
Mediterr J Hematol Infect Dis; 2015; 7(1):e2015033. PubMed ID: 25960861
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Impact of WT-1 Gene Expression in Egyptian Children with Acute Lymphoblastic Leukemia.
Hagag AA; Badraia IM; Hassan SM; Abd El-Lateef AE
Mediterr J Hematol Infect Dis; 2016; 8(1):e2016008. PubMed ID: 26740869
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of Prominin-1 Expression in Egyptian children with Acute Lymphoblastic Leukemia: Two centers Egyptian study.
Hagag AA; Elmashad GM; Abd El-Bar ES
J Cancer Res Ther; 2016; 12(2):627-33. PubMed ID: 27461622
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of CEBPA mutations and BAALC expression in acute myeloid leukemia Egyptian patients with normal karyotype.
El-Sharnouby JA; Ahmed LM; Taha AM; Kamal O
Egypt J Immunol; 2008; 15(1):131-43. PubMed ID: 20306678
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous changes in expression levels of BAALC and miR-326: a novel prognostic biomarker for childhood ALL.
Ghodousi ES; Aberuyi N; Rahgozar S
Jpn J Clin Oncol; 2020 Jun; 50(6):671-678. PubMed ID: 32129446
[TBL] [Abstract][Full Text] [Related]
7. Risk assessment in patients with acute myeloid leukemia and a normal karyotype.
Bienz M; Ludwig M; Leibundgut EO; Mueller BU; Ratschiller D; Solenthaler M; Fey MF; Pabst T
Clin Cancer Res; 2005 Feb; 11(4):1416-24. PubMed ID: 15746041
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Impact of Neuropilin-1 Expression in Egyptian Children with B-lineage Acute Lymphoblastic Leukemia.
Hagag AA; Nosair NA
Mediterr J Hematol Infect Dis; 2015; 7(1):e2015009. PubMed ID: 25574368
[TBL] [Abstract][Full Text] [Related]
9. Low ERG and BAALC expression identifies a new subgroup of adult acute T-lymphoblastic leukemia with a highly favorable outcome.
Baldus CD; Martus P; Burmeister T; Schwartz S; Gökbuget N; Bloomfield CD; Hoelzer D; Thiel E; Hofmann WK
J Clin Oncol; 2007 Aug; 25(24):3739-45. PubMed ID: 17646667
[TBL] [Abstract][Full Text] [Related]
10. mRNA overexpression of
Azizi Z; Rahgozar S; Moafi A; Dabaghi M; Nadimi M
Biomed Rep; 2015 May; 3(3):371-374. PubMed ID: 26137238
[No Abstract] [Full Text] [Related]
11. BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients.
Damiani D; Tiribelli M; Franzoni A; Michelutti A; Fabbro D; Cavallin M; Toffoletti E; Simeone E; Fanin R; Damante G
Am J Hematol; 2013 Oct; 88(10):848-52. PubMed ID: 23760853
[TBL] [Abstract][Full Text] [Related]
12. BAALC-associated gene expression profiles define IGFBP7 as a novel molecular marker in acute leukemia.
Heesch S; Schlee C; Neumann M; Stroux A; Kühnl A; Schwartz S; Haferlach T; Goekbuget N; Hoelzer D; Thiel E; Hofmann WK; Baldus CD
Leukemia; 2010 Aug; 24(8):1429-36. PubMed ID: 20535151
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of the
Xiao SJ; Shen JZ; Huang JL; Fu HY
Mol Clin Oncol; 2015 Jul; 3(4):880-888. PubMed ID: 26171200
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of rs62527607 [GT] single nucleotide polymorphism located in BAALC gene in children with acute leukemia using mismatch PCR-RFLP.
Nadimi M; Rahgozar S; Moafi A; Tavassoli M; Mesrian Tanha H
Cancer Genet; 2016; 209(7-8):348-53. PubMed ID: 27372260
[TBL] [Abstract][Full Text] [Related]
15. BAALC and ERG expression in acute myeloid leukemia with normal karyotype: impact on prognosis.
Eid MA; Attia M; Abdou S; El-Shazly SF; Elahwal L; Farrag W; Mahmoud L
Int J Lab Hematol; 2010 Apr; 32(2):197-205. PubMed ID: 19555438
[TBL] [Abstract][Full Text] [Related]
16. BAALC and ERG Expression in Egyptian Patients with Acute Myeloid Leukemia, Relation to Survival and Response to Treatment.
Soliman A; Aal AA; Afify R; Ibrahim N
Open Access Maced J Med Sci; 2016 Jun; 4(2):264-70. PubMed ID: 27335598
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of protease activated receptor-1 in children with acute lymphoblastic leukemia.
Hagag AA; Nosair NA; Ghaith FM; Elshenawy EH
Mediterr J Hematol Infect Dis; 2014; 6(1):e2014029. PubMed ID: 24804002
[TBL] [Abstract][Full Text] [Related]
18. WT-1, BAALC, and ERG Expressions in Iranian Patients with Acute Myeloid Leukemia Pre- and Post-chemotherapy.
Mehralizadeh H; Aliparasti MR; Talebi M; Salekzamani S; Almasi S; Raeisi M; Yousefi M; Movassaghpour A
Adv Pharm Bull; 2021 Jan; 11(1):197-203. PubMed ID: 33747867
[No Abstract] [Full Text] [Related]
19. BAALC and ERG expression levels at diagnosis have no prognosis impact on acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation.
Zhang J; Shi J; Zhang G; Zhang X; Yang X; Yang S; Wang J; Ke X; Fu L
Ann Hematol; 2018 Aug; 97(8):1391-1397. PubMed ID: 29696374
[TBL] [Abstract][Full Text] [Related]
20. ERG expression is an independent prognostic factor and allows refined risk stratification in cytogenetically normal acute myeloid leukemia: a comprehensive analysis of ERG, MN1, and BAALC transcript levels using oligonucleotide microarrays.
Metzeler KH; Dufour A; Benthaus T; Hummel M; Sauerland MC; Heinecke A; Berdel WE; Büchner T; Wörmann B; Mansmann U; Braess J; Spiekermann K; Hiddemann W; Buske C; Bohlander SK
J Clin Oncol; 2009 Oct; 27(30):5031-8. PubMed ID: 19752345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
